Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 9 studies | 18% ± 4% | |
endothelial cell | 5 studies | 19% ± 2% | |
epithelial cell | 5 studies | 26% ± 8% | |
mesothelial cell | 4 studies | 21% ± 4% | |
hepatocyte | 4 studies | 48% ± 27% | |
basal cell | 3 studies | 19% ± 3% | |
astrocyte | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 9638.36 | 245 / 245 | 100% | 40.70 | 500 / 502 |
breast | 100% | 11235.61 | 459 / 459 | 99% | 42.41 | 1112 / 1118 |
esophagus | 100% | 6998.99 | 1445 / 1445 | 99% | 52.59 | 182 / 183 |
stomach | 100% | 6950.78 | 359 / 359 | 99% | 41.30 | 284 / 286 |
intestine | 100% | 6976.97 | 966 / 966 | 99% | 37.28 | 523 / 527 |
thymus | 100% | 7481.84 | 652 / 653 | 99% | 43.41 | 601 / 605 |
lung | 100% | 9734.03 | 578 / 578 | 99% | 45.98 | 1142 / 1155 |
liver | 100% | 22904.03 | 226 / 226 | 99% | 62.22 | 401 / 406 |
skin | 100% | 12861.25 | 1809 / 1809 | 99% | 40.73 | 465 / 472 |
uterus | 100% | 12260.11 | 170 / 170 | 98% | 35.93 | 451 / 459 |
ovary | 100% | 19971.64 | 180 / 180 | 98% | 43.51 | 422 / 430 |
kidney | 100% | 4699.63 | 89 / 89 | 98% | 44.94 | 883 / 901 |
bladder | 100% | 7816.29 | 21 / 21 | 98% | 31.44 | 493 / 504 |
pancreas | 96% | 5044.22 | 315 / 328 | 100% | 48.65 | 178 / 178 |
adrenal gland | 100% | 13429.28 | 258 / 258 | 72% | 17.57 | 165 / 230 |
brain | 74% | 1901.25 | 1949 / 2642 | 98% | 26.81 | 690 / 705 |
adipose | 100% | 12808.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 24.65 | 29 / 29 |
muscle | 100% | 11781.47 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6785.78 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.71 | 1 / 1 |
blood vessel | 100% | 8454.47 | 1333 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 31.96 | 78 / 80 |
heart | 97% | 5588.76 | 834 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 80% | 3803.53 | 740 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031667 | Biological process | response to nutrient levels |
GO_2000064 | Biological process | regulation of cortisol biosynthetic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0097305 | Biological process | response to alcohol |
GO_0009051 | Biological process | pentose-phosphate shunt, oxidative branch |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0004345 | Molecular function | glucose-6-phosphate dehydrogenase activity |
GO_0017057 | Molecular function | 6-phosphogluconolactonase activity |
GO_0047935 | Molecular function | glucose 1-dehydrogenase (NADP+) activity |
GO_0050661 | Molecular function | NADP binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0047936 | Molecular function | glucose 1-dehydrogenase [NAD(P)+] activity |
GO_0047934 | Molecular function | glucose 1-dehydrogenase (NAD+) activity |
Gene name | H6PD |
Protein name | GDH/6PGL endoplasmic bifunctional protein [Includes: Hexose-6-phosphate dehydrogenase (Glucose 1-dehydrogenase) (GDH) (EC 1.1.1.47) (Glucose-6-phosphate dehydrogenase) (EC 1.1.1.363); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)] |
Synonyms | GDH |
Description | FUNCTION: Bifunctional enzyme localized in the lumen of the endoplasmic reticulum that catalyzes the first two steps of the oxidative branch of the pentose phosphate pathway/shunt, an alternative to glycolysis and a major source of reducing power and metabolic intermediates for biosynthetic processes (By similarity). Has a hexose-6-phosphate dehydrogenase activity, with broad substrate specificity compared to glucose-6-phosphate 1-dehydrogenase/G6PD, and catalyzes the first step of the pentose phosphate pathway . In addition, acts as a 6-phosphogluconolactonase and catalyzes the second step of the pentose phosphate pathway (By similarity). May have a dehydrogenase activity for alternative substrates including glucosamine 6-phosphate and glucose 6-sulfate (By similarity). The main function of this enzyme is to provide reducing equivalents such as NADPH to maintain the adequate levels of reductive cofactors in the oxidizing environment of the endoplasmic reticulum . By producing NADPH that is needed by reductases of the lumen of the endoplasmic reticulum like corticosteroid 11-beta-dehydrogenase isozyme 1/HSD11B1, indirectly regulates their activity . . |
Accessions | ENST00000377403.7 [O95479-1] ENST00000602477.1 [O95479-2] O95479 |